These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20089735)

  • 1. How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?
    Itäaho K; Laakkonen L; Finel M
    Drug Metab Dispos; 2010 Apr; 38(4):687-96. PubMed ID: 20089735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10.
    Sten T; Qvisen S; Uutela P; Luukkanen L; Kostiainen R; Finel M
    Drug Metab Dispos; 2006 Sep; 34(9):1488-94. PubMed ID: 16763014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key amino acid residues responsible for the differences in substrate specificity of human UDP-glucuronosyltransferase (UGT)1A9 and UGT1A8.
    Fujiwara R; Nakajima M; Yamanaka H; Yokoi T
    Drug Metab Dispos; 2009 Jan; 37(1):41-6. PubMed ID: 18832479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
    Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.
    Itäaho K; Mackenzie PI; Ikushiro S; Miners JO; Finel M
    Drug Metab Dispos; 2008 Nov; 36(11):2307-15. PubMed ID: 18719240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
    Kerdpin O; Mackenzie PI; Bowalgaha K; Finel M; Miners JO
    Drug Metab Dispos; 2009 Sep; 37(9):1948-55. PubMed ID: 19487247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid positions 69-132 of UGT1A9 are involved in the C-glucuronidation of phenylbutazone.
    Nishiyama T; Fujishima M; Masuda Y; Izawa T; Ohnuma T; Ogura K; Hiratsuka A
    Arch Biochem Biophys; 2008 Oct; 478(1):75-80. PubMed ID: 18602884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amino acid substitutions at positions 33 and 37 on UDP-glucuronosyltransferase 1A9 (UGT1A9) activity and substrate selectivity.
    Korprasertthaworn P; Rowland A; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
    Biochem Pharmacol; 2012 Dec; 84(11):1511-21. PubMed ID: 22981363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of dobutamine monoglucuronides and glucuronidation of dobutamine by recombinant human UDP-glucuronosyltransferases.
    Alonen A; Aitio O; Hakala K; Luukkanen L; Finel M; Kostiainen R
    Drug Metab Dispos; 2005 May; 33(5):657-63. PubMed ID: 15689500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases.
    Kuuranne T; Kurkela M; Thevis M; Schänzer W; Finel M; Kostiainen R
    Drug Metab Dispos; 2003 Sep; 31(9):1117-24. PubMed ID: 12920167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An active and water-soluble truncation mutant of the human UDP-glucuronosyltransferase 1A9.
    Kurkela M; Mörsky S; Hirvonen J; Kostiainen R; Finel M
    Mol Pharmacol; 2004 Apr; 65(4):826-31. PubMed ID: 15044611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfinpyrazone C-glucuronidation is catalyzed selectively by human UDP-glucuronosyltransferase 1A9.
    Kerdpin O; Elliot DJ; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2006 Dec; 34(12):1950-3. PubMed ID: 16985098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10.
    Mizuma T
    Int J Pharm; 2009 Aug; 378(1-2):140-1. PubMed ID: 19486934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone.
    Nishiyama T; Kobori T; Arai K; Ogura K; Ohnuma T; Ishii K; Hayashi K; Hiratsuka A
    Arch Biochem Biophys; 2006 Oct; 454(1):72-9. PubMed ID: 16949544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human UDP glucuronosyltransferase, UGT1A10, glucuronidates mycophenolic acid.
    Mojarrabi B; Mackenzie PI
    Biochem Biophys Res Commun; 1997 Sep; 238(3):775-8. PubMed ID: 9325166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylalanine 90 and 93 are localized within the phenol binding site of human UDP-glucuronosyltransferase 1A10 as determined by photoaffinity labeling, mass spectrometry, and site-directed mutagenesis.
    Xiong Y; Bernardi D; Bratton S; Ward MD; Battaglia E; Finel M; Drake RR; Radominska-Pandya A
    Biochemistry; 2006 Feb; 45(7):2322-32. PubMed ID: 16475821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.
    Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S
    Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10.
    Gramec Skledar D; Troberg J; Lavdas J; Peterlin Mašič L; Finel M
    Xenobiotica; 2015; 45(6):511-9. PubMed ID: 25547628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid residue ILE211 is essential for the enzymatic activity of human UDP-glucuronosyltransferase 1A10 (UGT1A10).
    Martineau I; Tchernof A; Bélanger A
    Drug Metab Dispos; 2004 Apr; 32(4):455-9. PubMed ID: 15039300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation.
    Lewis BC; Mackenzie PI; Elliot DJ; Burchell B; Bhasker CR; Miners JO
    Biochem Pharmacol; 2007 May; 73(9):1463-73. PubMed ID: 17223084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.